Overview

Hydrocortisone Use After Etomidate in Intensive Care

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
the objective of the study is to assess the value of substitution with 200mg/24h of hydrocortisone for 48 hours for patients in intensive care who have received a single injection of etomidate
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital, Grenoble
Treatments:
Cortisol succinate
Etomidate
Hydrocortisone
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone acetate